Drugs / Aponermin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06924424 | Mar 2025 → Dec 2026 expected | plasma cell myeloma | Peking University People's Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aponermin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06924424 ↗ |
| Route | Intravenous | “Aponermin10mg/kg d1-5 ivgtt” NCT06924424 ↗ |